Technically Speakin...
Health Care: Health Services
BioMimetic Therapeutics Inc. (BMTI: NASDAQ)
$2.49 -0.03 | -1.19%
06/01/12 - 04:00 PM ET
Company Income Statement
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Sales | 1.72M | 1.47M | 1.57M | 3.12M |
| Cost of Sales | 53.43K | 17.25K | 5.67K | 0.00 |
| Gross Operating Profit | 1.67M | 1.46M | 1.57M | 3.12M |
| Selling, General, and Administrative Expenses | 16.03M | 15.16M | 11.51M | 11.25M |
| Research & Development | 14.69M | 17.97M | 21.10M | 24.56M |
| Operating Income before D & A (EBITDA) | -29.06M | -31.67M | -31.04M | -32.70M |
| Depreciation & Amortization | 1.29M | 2.89M | 3.90M | 4.09M |
| Interest Income | 0.00 | 0.00 | 0.00 | 405.16K |
| Other Income - Net | -2.84M | 630.00K | 14.09M | 28.53M |
| Special Income / Charges | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income Before Interest Expenses (EBIT) | -33.19M | -33.93M | -20.85M | -7.85M |
| Interest Expense | 4.32K | 3.60K | 308.13K | 158.03K |
| Pre-Tax Income | -33.19M | -33.94M | -21.16M | -8.00M |
| Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing Operations | -33.19M | -33.94M | -21.16M | -8.00M |
| Net Income From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Total Operations | -33.19M | -33.94M | -21.16M | -8.00M |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | -33.19M | -33.94M | -21.16M | -8.00M |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-33.19M | -33.94M | -21.16M | -8.00M |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | -33.19M | -33.94M | -21.16M | -8.00M |
| Basic EPS from Continuing Ops. | -1.19 | -1.38 | -1.03 | -0.43 |
| Basic EPS from Discontinued Ops. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Total Operations | -1.19 | -1.38 | -1.03 | -0.43 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | -1.19 | -1.38 | -1.03 | -0.43 |
| Basic Normalized Net Income/Share | -1.19 | -1.38 | -1.03 | -0.43 |
| EPS fr Continuing Ops. | -1.19 | -1.38 | -1.03 | -0.43 |
| EPS fr Discontinued Ops | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Total Ops. | -1.19 | -1.38 | -1.03 | -0.43 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | -1.19 | -1.38 | -1.03 | -0.43 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-1.19 | -1.38 | -1.03 | -0.43 |
| Dividends Paid per Share | 0.00 | 0.00 | 0.00 | 0.00 |
Portfolios with BMTI
- Portfolio NameUser Type
- ContributorStocks With Big Insider Buy...
- Usertest
- ContributorBarron's Activist Stocks 12...
- Userjcweddell Portfolio 1
- Userrazzmazz Portfolio 1
- ContributorBarron's Activist Stocks 7-...
- ContributorBarron's Insider Purchases ...
- Useramarmaharaj Portfolio 1
- UserGet this thing started
- UserBREAKOUTS2008
Latest BMTI Headlines from TheStreet
- BioMimetic Stock Hits New 52-Week Low (BMTI) 07.27.11 | 04:07 pm
- BioMimetic Stock Hits New 52-Week Low (BMTI) 07.19.11 | 12:07 pm
- BioMimetic Stock Hits New 52-Week Low (BMTI) 07.11.11 | 11:07 am
- BioMimetic Stock Hits New 52-Week Low (BMTI) 07.01.11 | 12:07 pm
- BioMimetic Stock Hits New 52-Week Low (BMTI) 06.23.11 | 11:06 am
- BioMimetic Stock Hits New 52-Week Low (BMTI) 06.08.11 | 12:06 pm
- BioMimetic Stock Falls On Unusually High Volume (BMTI) 05.13.11 | 10:05 am
- BioMimetic Stock Gaps Down On Today's Open (BMTI) 05.10.11 | 09:05 am
- Insiders Buy and Sell RealD IPO 07.20.10 | 09:07 am
- Stock Offerings: First of Long Island 07.15.10 | 09:07 am
Press Releases for BMTI
- BioMimetic Therapeutics, Inc. Reports First Quarter 2012 Earnings Results - Business Wire 05.09.12 | 04:05 pm
- BioMimetic Therapeutics, Inc. To Report First Quarter 2012 Financial Results On May 9 - Business Wire 05.07.12 | 11:05 am
- BioMimetic Therapeutics, Inc. Reports Fourth Quarter And Year-End 2011 Earnings Results - Business Wire 03.13.12 | 04:03 pm
- BioMimetic Therapeutics, Inc. To Report 2011 Fourth Quarter And Year-End Financial Results On March 13 - Business Wire 03.09.12 | 02:03 pm
- BioMimetic Therapeutics, Inc. To Introduce Augmatrix™ Biocomposite Bone Graft Product Line At AAOS - Business Wire 02.08.12 | 09:02 am
- BioMimetic Therapeutics, Inc. To Highlight Product Development Activities At ORS And AAOS Meetings - Business Wire 02.06.12 | 04:02 pm
- BioMimetic Therapeutics, Inc. To Present At The 30th Annual J.P. Morgan Healthcare Conference - Business Wire 01.10.12 | 11:01 am
- BioMimetic Therapeutics Announces Approval To Market GEM 21S® In The European Union - Business Wire 01.03.12 | 04:01 pm
- BioMimetic Therapeutics Receives Augment® Bone Graft PMA Response Letter From FDA - Business Wire 01.03.12 | 04:01 pm
- BioMimetic Therapeutics, Inc. Reports Third Quarter 2011 Earnings Results - Business Wire 11.08.11 | 04:11 pm
Partner Headlines for BMTI
- Speculative Biotech: A Speculation Trader's Dream and Nightmare - Seeking Alpha 11.03.11 | 09:11 am
- Earnings Report Card, Regenerative Medicine Universe Edition - Seeking Alpha 08.11.11 | 09:08 am
- Morning Market Losers (BMTI, NSPH, HEAT, PAL) - Benzinga 05.10.11 | 09:05 am
- 9 Healthcare Companies Expecting May Catalysts - Seeking Alpha 05.04.11 | 08:05 am
- BioMimetic: What the Bulls Are Seeing - Seeking Alpha 03.18.11 | 08:03 am
- Early-Market Movers: Vivus, Amedisys - Fox Business 07.13.10 | 09:07 am
